Hayet Boudjani, Giulia Fadda, Gabrielle Dufort, Jack Antel, Paul Giacomini, Myriam Levesque-Roy, Maryam Oskoui, Pierre Duquette, Alexandre Prat, Marc Girard, Rose-Marie Rebillard, Inge Meijer, Elana Pinchefsky, Cam-Tu Emilie Nguyen, Elsa Rossignol, Jacinthe Rouleau, Oliver Blanchard, Nicole Khairallah, Philippe Beauchemin, Anne-Marie Trudelle, Emmanuelle Lapointe, Alexander Saveriano, Catherine Larochelle
BACKGROUND: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently described neuroinflammatory demyelinating disease. OBJECTIVE: To better understand the clinical spectrum, risk factors and outcomes in MOGAD. METHODS: Retrospective cohort study including all subjects harboring anti-MOG antibodies identified in major academic hospitals across the province of Quebec. RESULTS: We identified 45 MOGAD cases...
June 5, 2023: Multiple Sclerosis and related Disorders